TRANSDERMAL BIOACTIVE NATURAL JOINT CARTILAGE REPAIR PATCH
Patent Information
- Application Number
- TR202601597
- Authority / Receiving Office
- TR · TR
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-02-03
- Publication Date
- 2026-06-22
Smart Images
Figure 00000008_0000 
Figure 00000009_0000
Abstract
Description
1 TARIFF 5 TRANSDERMAL BIOACTIVE NATURAL JOINT CARTILAGE REPAIR PATCH Technical Area This invention is designed for the repair of articular cartilage and contains entirely natural bioactive components. It relates to a transdermal patch containing [material name]. This invention supports the restoration and natural regeneration of articular cartilage and cartilage It relates to a formulation that repairs tissue. State of the Art There are various methods currently available for repairing articular cartilage. Surgical methods (microfracture, mosaicplasty, etc.) and pharmacological treatments (NSAIDs, corticosteroid injections) It is widely used. However, current methods are generally invasive and have limited effectiveness. They have a duration or may cause side effects. Transdermal systems apply the agent through the skin. Solutions containing natural bioactive ingredients that target joint cartilage while facilitating substance transfer. It is not available. Purpose of the Invention 25 The aim of this invention is to promote the regeneration of articular cartilage through natural bioactive components. Non-invasive, safe and strengthening of the cartilage tissue supporting and surrounding the joint. The goal is to develop an effective transdermal patch. This invention offers both an alternative to pharmacological treatments and... It provides a solution that supports existing treatments. 30 To achieve the objectives described above, the present invention utilizes transdermal bioactive natural substances. This describes an articular cartilage repair patch. The patch in question has at least one back layer, at least... It contains a layer of bioactive natural compounds and at least one adhesive layer. 2 In a preferred configuration of the invention, the aforementioned bioactive natural compound layer consists of animal-derived 5 at least one ingredient selected from oils, vegetable oils, beeswax, vitamins and antioxidants. It includes. In another preferred configuration of the invention, the aforementioned bioactive natural compound layer is attached to the joint. 10 natural molecules that stimulate regeneration in cartilage cells and reduce inflammation It includes. In another preferred configuration of the invention, the aforementioned adhesive layer is in continuous contact with the skin. By providing this, it facilitates the transdermal passage of bioactive compounds. In another preferred configuration of the invention, the aforementioned patch would provide controlled release. It is formulated as follows. In another preferred configuration of the invention, the aforementioned patch consists of the epidermis, dermis, and subcutaneous tissue. It contains bioactive molecules that can pass through the tissue (3) and reach the joint cartilage. 20 In another preferred configuration of the invention, the aforementioned patch is used for arthritis, cartilage damage, and joint problems. It is used in the treatment or improvement of inflammation and degenerative joint disorders. In another preferred configuration of the invention, the aforementioned patch is 25 inches from the articular cartilage. invasive that supports regeneration and strengthens the cartilage tissue surrounding the joint It is a non-invasive, safe, and effective transdermal patch. In another preferred configuration of the invention, the patch in question is manufactured under sterile conditions. In another preferred configuration of the invention, the aforementioned patch is a medical device or pharmaceutical product 30 It is presented in packaging that conforms to standards. In another preferred configuration of the invention, the patch mentioned involves the application of bioactive compounds to a specific area. It ensures a continuous and balanced release through the skin over a period of time. 35 3 Figure Description 5 Figure 1 schematically shows how the transdermal patch of the invention acts on cartilage through the skin layers. as shown. Figure 2 shows the structural composition of the patch: back layer, bioactive natural compound layer 10 and adhesive layer. Explanation of References 1 – Epidermis 2 – Dermis 3 - Subcutaneous tissue 4 - Cartilage tissue 5- Transdermal patch 6 - Back layer 7 - Bioactive natural compound layer 8 - Adhesive layer Detailed Description of the Invention The invention is a design of a multilayer transdermal patch (5) containing natural bioactive components. The invention is based on the transdermal patch; a back layer (6) that provides protection from the external environment. a bioactive natural compound layer (7) carrying active ingredients and an adhesive 20 that ensures adhesion to the skin It consists of (8) layers. The patch in question (5) provides controlled and bioactive natural components to the joint area via the skin. By providing continuous release, it supports the regeneration of cartilage tissue. Bioactive. 4 natural compound layer (7); animal fat (lard or similar) / tallow derivatives, vegetable oils, 5 beeswax, other natural molecules that support joint cartilage regeneration, vitamins and It contains at least one or more components selected from antioxidants. These components, It is formulated with auxiliary agents that facilitate transdermal penetration. These compounds, It reaches the articular cartilage by passing through the epidermis, dermis, and subcutaneous tissue via a transdermal route. And here it exhibits anti-inflammatory, antioxidant and regenerative effects. The invention is used for arthritis, cartilage 10 in the treatment or improvement of joint damage, joint inflammation and degenerative joint disorders Suitable for use. Can be produced on an industrial scale, prepared under sterile conditions, and used as a medical device. or can be packaged in accordance with pharmaceutical product standards. Therefore, the invention is based on existing An innovative solution that provides a more natural, safe, and long-lasting effect compared to treatments. It offers. 15 When the patch (5) is applied to the skin, the bioactive substances pass through the epidermis (1) and dermis (2) layers. It passes through and diffuses into the cartilage tissue (4) in the joint area. This mechanism, cartilage It supports the metabolism of chondrocytes, reduces inflammation, and aids in the repair process. It encourages. 20 Figure 1 schematically shows the application of the invention's transdermal patch (5) on the skin. The figure shows the epidermis (1), dermis (2), subcutaneous tissue (3) and cartilage tissue (4). It has been stated. Figure 2 shows the structural composition of the transdermal patch (5) of the invention. This composition includes the back backing layer (6), bioactive natural compound layer (7), adhesive layer (8) It consists of. Transdermal Bioactive Natural Joint Cartilage Repair Patch - Sample Formulation Table 30 The table below shows a typical formulation example of the transdermal patch that is the subject of the invention. The table includes the components, ratios, and functions of each layer. 5 How the invention can be applied to industry. The invention has a wide range of applications in the pharmaceutical industries. Transdermal patches, serial production using multilayer film technology, suitable for industrial production processes. It can be put into production. The product strengthens the cartilage tissue surrounding the joint. treatment of diseases, support for sports injuries and age-related cartilage prevention of degeneration
Claims
6 REQUIREMENTS 5 1. Transdermal bioactive natural articular cartilage repair patch (5), with at least one back layer (6), by containing at least one bioactive natural compound layer (7) and at least one adhesive layer (8) It is characteristic.
2. The patch in claim 1 is (5), and the aforementioned bioactive natural compound layer (7) is animal fat, by containing at least one ingredient selected from vegetable oils, beeswax, vitamins and antioxidants It is characteristic.
3. The patch (5) in claim 1 or 2, the articular cartilage of the bioactive natural compound layer (7) 15 because it contains natural molecules that stimulate regeneration in cells and reduce inflammation. It is characteristic.
4. The patch (5) is according to any of the previous requests, and its adhesive layer (8) is continuous with the skin. It is characterized by facilitating the transdermal passage of bioactive compounds through contact. 20 5. A patch (5) according to any of the previous requests, which will provide controlled release. It is characterized by being formulated.
6. Patch (5) according to any of the previous requests, epidermis (1), dermis (2) and subcutaneous 25 It is characterized by containing bioactive molecules that can pass through the tissue (3) and reach the articular cartilage.
7. A patch (5) according to any of the previous requests, for arthritis, cartilage damage, joint inflammation and It is characterized by its use in the treatment or improvement of degenerative joint disorders.
8. A patch (5) according to any of the previous requests, and regeneration of joint cartilage. non-invasive, safe that supports and strengthens the cartilage tissue surrounding the joint (4) and is characterized by being an effective transdermal patch. 7 9. The patch is (5) according to any of the previous requests and is manufactured under sterile conditions. It is characterized by its...
10. A patch (5) according to any of the previous requests, medical device or pharmaceutical product It is characterized by being presented in packaging that meets standards.
11. According to any of the previous claims, the patch will release bioactive compounds for a specified period of time. It is characterized by its ability to ensure a continuous and balanced release of hormones through the skin.